Literature DB >> 7370975

Structure and reactivity of nitrosocimetidine.

A B Foster, M Jarman, D Manson, H R Schulten.   

Abstract

The major product of reaction of cimetidine in 2 M hydrochloric acid in the prescence of excess sodium nitrite is a mono-nitroso derivative, the structure of which has been determined by the application of field desorption mass and proton magnetic resonance spectrometry. The methylating ability of nitrosocimetidine in phosphate buffer at pH 7 towards 3,4-dichlorobenzenethiol is comparable to that of the known gastric carcinogen, N-methyl-N'-nitro-N-nitrosoguanidine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7370975     DOI: 10.1016/0304-3835(80)90139-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  New drugs for peptic ulcer.

Authors: 
Journal:  Br Med J       Date:  1980-07-12

Review 2.  H2-receptor antagonists and gastric cancer.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun

3.  Does cimetidine cause gastric cancer?

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-11

4.  Effect of chronic cimetidine ingestion on fundic and antral epithelial proliferation in the rat.

Authors:  G L Eastwood; G F Quimby
Journal:  Dig Dis Sci       Date:  1983-01       Impact factor: 3.199

Review 5.  Environmental causes of esophageal cancer.

Authors:  Farin Kamangar; Wong-Ho Chow; Christian C Abnet; Sanford M Dawsey
Journal:  Gastroenterol Clin North Am       Date:  2009-03       Impact factor: 3.806

6.  pH-dependent degradation of nitrosocimetidine and its mechanisms.

Authors:  N Frank; S Sato; M Tsuda
Journal:  Jpn J Cancer Res       Date:  1988-10

7.  Estimation of nizatidine gastric nitrosatability and product toxicity via an integrated approach combining HILIC, in silico toxicology, and molecular docking.

Authors:  Rania El-Shaheny; Mohamed Radwan; Koji Yamada; Mahmoud El-Maghrabey
Journal:  J Food Drug Anal       Date:  2019-08-22       Impact factor: 6.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.